Canakinumab Subcutaneous and Morphabond
Determining the interaction of Canakinumab Subcutaneous and Morphabond and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, Avinza, MS Contin, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: MorphaBond ER, Morphabond ER
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-MorphaBond ER
- Canakinumab Subcutaneous-Morphine
- Canakinumab Subcutaneous-Morphine (Systemic)
- Canakinumab Subcutaneous-Morphine and naltrexone
- Canakinumab Subcutaneous-Morphine Epidural
- Canakinumab Subcutaneous-Morphine ER
- Morphabond-Canasa
- Morphabond-Canasa Pac rectal
- Morphabond-Canasa rectal
- Morphabond-Cancidas
- Morphabond-Candesartan
- Morphabond-Candesartan and Hydrochlorothiazide